Yu et al. [10] reported that the mutation status of five gene signatures, CDH10, COL6A3, SMAD4, TMEM132D and VCAN, could predict the survival of CRC patients in two independent cohorts. The gene discussed is SMAD4; the disease is colorectal carcinoma.